Kiora Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $20 | $16,000 | $283 |
Gross Profit | 2 | 15,983 | 275 |
EBITDA | -2,418 | 13,469 | -6,780 |
EBIT | -2,436 | 13,453 | -6,788 |
Net Income | -2,221 | 13,453 | -2,268 |
Net Change In Cash | 20 | 16,000 | 283 |
Free Cash Flow | -3,784 | 13,624 | -2,581 |
Cash | 6,575 | 31,276 | 2,454 |
Basic Shares | 4,170 | 35,025 | 7,705 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $12 | $12 |
Gross Profit | -4,027 | -134 | -227 | -188 |
EBITDA | -12,350 | -13,553 | -13,729 | -6,645 |
EBIT | -12,412 | -13,688 | -13,956 | -6,845 |
Net Income | -12,513 | -13,583 | -16,394 | -8,091 |
Net Change In Cash | 0 | 0 | 12 | 12 |
Free Cash Flow | -9,556 | -10,428 | -10,951 | -7,450 |
Cash | 2,454 | 5,964 | 7,854 | 1,185 |
Basic Shares | 538 | 732 | 241 | 114 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.81 |
2024-06-30 | -$0.53 |
2024-03-31 | $0.38 |
2023-12-31 | -$0.47 |
